Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia
Crossref DOI link: https://doi.org/10.1007/s00384-015-2461-x
Published Online: 2015-12-22
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Calleja, José Luis
,
Delgado, Salvadora
del Val, Adolfo
Hervás, Antonio
Larraona, José Luis
Terán, Álvaro
Cucala, Mercedes
Mearin, Fermín
Funding for this research was provided by:
Vifor Pharma España SL
License valid from 2015-12-22